ELDN (Eledon Pharmaceuticals) Accounts Payable: $6.59 Mil (As of Mar. 2026)


ELDN Eledon Pharmaceuticals Inc ELDN
27 GF Score
Price $3.95
! 2 Warning Signs
View Full Analysis

What is Eledon Pharmaceuticals Accounts Payable?

Eledon Pharmaceuticals ELDN +1.28% 27 Accounts Payable is $6.59 Mil as of Mar. 2026. GuruFocus rates ELDN with a GF Score™ of 27/100. The stock has 2 warning signs investors should review.

Eledon Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2026 was $6.59 Mil.

Eledon Pharmaceuticals's quarterly Accounts Payable declined from Sep. 2025 ($4.63 Mil) to Dec. 2025 ($3.63 Mil) but then increased from Dec. 2025 ($3.63 Mil) to Mar. 2026 ($6.59 Mil).

Eledon Pharmaceuticals's annual Accounts Payable increased from Dec. 2023 ($0.97 Mil) to Dec. 2024 ($5.83 Mil) but then declined from Dec. 2024 ($5.83 Mil) to Dec. 2025 ($3.63 Mil).

Eledon Pharmaceuticals Accounts Payable Related Terms

Eledon Pharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Eledon Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eledon Pharmaceuticals Accounts Payable Chart

Eledon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 2.20 0.97 5.83 3.63

Eledon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 5.83 4.63 3.63 6.59
ELDN
27GF Score
Eledon Pharmaceuticals Inc ELDN
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eledon Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $6.59 Mil mean?
Eledon Pharmaceuticals (ELDN) has a Accounts Payable of $6.59 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Eledon Pharmaceuticals and its competitors.
Is Eledon Pharmaceuticals' Accounts Payable too high?
Eledon Pharmaceuticals' current Accounts Payable is $6.59 Mil. Overall, Eledon Pharmaceuticals has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Eledon Pharmaceuticals' Accounts Payable compare to ZNTL and GLSI?
Eledon Pharmaceuticals' Accounts Payable of $6.59 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Eledon Pharmaceuticals and its competitors. Eledon Pharmaceuticals's current Accounts Payable is $6.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eledon Pharmaceuticals stock overvalued right now?
Eledon Pharmaceuticals (ELDN) has a current Accounts Payable of $6.59 Mil. The current Accounts Payable is $6.59 Mil. Eledon Pharmaceuticals' overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Eledon Pharmaceuticals (ELDN), the current Accounts Payable is $6.59 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eledon Pharmaceuticals Business Description

Other Exchanges 2TK:Germany
Address 19800 MacArthur Boulevard, Suite 250, Irvine, CA, USA, 92612
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
27GF Score

Get the complete analysis for ELDN

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.95
Price